Patients turn into profits for hotels with the right medical connections
Tampa Bay Times – Feb. 3
Moffitt Cancer Center has been ranked as the sixth-best cancer center in the country, according to U.S. News and World Report. Its patients booked 34,801 discounted room nights at seven hotels around the area in the 2015/2016 fiscal year, up from 25,835 room nights the year before.
Business Observer – Feb. 3
How do you get employees engaged in the work the firm is doing, when the projects are so large?
The clients who we work for touch a lot of our people directly. Moffitt Cancer Center has saved the lives of multiple people who work in this company. That touches them and their families directly. When people recognize that this isn’t just a construction project, but that this is my cancer center or the place where my kids were born, it’s a big deal. That’s when employees buy into it. That allows us to get connected to the places where we work.
UCF researchers win state grants to study Zika virus
Orlando Sentinel – Feb. 2
University of Miami received the highest amount for $13 million. University of Florida, Florida International University, Florida State University and University of South Florida received more than $2 million each. Other awardees, including Moffitt Cancer Center and The Scripps Research Institute received about $200,000 each.
Combining and Sequencing BCR-ABL TKIs with Omacetaxine in CML
OncLive – Feb. 2
Javier Pinilla-Ibarz, MD, PhD: The use of omacetaxine in combination with tyrosine kinase inhibitors early in the disease is not a common practice. It’s because most of the tyrosine kinase inhibitors are really effective in the frontline or even in the second line.
Considering Lenalidomide in Non-Del 5q MDS
OncLive – Feb. 2
Rami S. Komrokji, MD: I think there a couple of important points you mentioned. I think deletion 5q is a more settled story. Some decisions models in the past looked at the threshold where starting a treatment before ESA would be more beneficial.
Touched by an angel: Cancer battle inspires volunteer
Windermere Observer – Feb. 2
Yet, despite the recognition and 15 years of service, Guida has no plans to quit anytime soon. She feels she’s only repaying a debt of kindness she once received from volunteers during her chemotherapy sessions at the H. Lee Moffitt Cancer Center in Tampa.
Gov. Rick Scott awards USF, Moffitt grant funds to fight Zika
Tampa Bay Times – Feb. 2
The University of South Florida received nearly $2.5 million for Zika research on Wednesday as Gov. Rick Scott announced grants to 10 universities and research institutions in Florida to speed up development of a vaccine. The Moffitt Cancer Center also received almost $200,000, according to a news release.
State money going to Universities for Zika Research
WTXL – Feb. 1
Researchers at eight universities, Moffitt Cancer Center and The Scripps Research Institute will share $25 million in grants as the state looks to combat the mosquito-borne Zika virus, Gov. Rick Scott's office announced Wednesday. Also seen on WJXT, WFSU.
UM receives $13 million grant from state to fund Zika research
Miami Herald – Feb. 1
After a competitive process and recommendations from the Biomedical Research Advisory Council at the DOH, UM received the largest share. Florida Atlantic, Florida International and Florida State universities and the Moffitt Cancer Center and Scripps Research Institute also received grants.
Lion Biotechnologies hoping to wow with tumor-infiltrating lymphocytes cancer therapy
MedCity News – Feb. 1
According to the company’s website the therapy — which was licensed from NCI— is currently being tested in trials to treat metastatic melanoma at NCI, MD Anderson Cancer Center, and the H. Lee Moffitt Cancer & Research Institute. Per ClinicalTrials.Gov, the estimated enrollment in this trial is 20.
Cure on Wheels
WFTS – Jan. 31
Approximately a dozen bicyclists (many who are cancer survivors) are riding 325 miles over four days from Moffitt Cancer Center to Tallahassee to raise money and awareness for cancer research.
Variations in AML Therapies Lead to Improved Outcomes
Clinical Oncology News – Jan. 31
“More patients were transplanted in CR [complete response], and CPX-351 was associated with lower induction-related morbidity and mortality, suggesting patients may be transplanted in better condition,” reported Jeffrey E. Lancet, MD, the section head of leukemia/myelodysplasia at Moffitt Cancer Center, in Tampa, Fla.
Patient Selection Considerations With Iron Chelation Therapy in MDS
OncLive – Jan. 31
Rami S. Komrokji, MD: I totally agree with you. I think you have to have that benefit/risk discussion with the patient. So, basically, there is some evidence that there is benefit of iron chelation. We know that iron overload is probably the same whether it’s thalassemia, MDS, or myelofibrosis.
Toxicity for Omacetaxine in CML
OncLive – Jan. 31
Javier Pinilla-Ibarz, MD, PhD: Omacetaxine is our current treatment alternative for a patient who has failed or is intolerant to 2 or more TKIs. I had to really discuss that many patients—older patients, mainly, or even younger population of patients—may have intolerance to multiple tyrosine kinases.
St. Petersburg City Council chair Darden Rice announces she has breast cancer
Tampa Bay Times – Jan. 30
Rice, 46, said Monday that she's undergoing treatment, which will include surgery, radiation and endocrine therapy, under the supervision of doctors at St. Anthony's Hospital in St. Petersburg and H. Lee Moffitt Cancer Center in Tampa.
Cape Coral's Aubuchon will ride his bike from Tampa to Tallahassee to raise money and awareness for cancer
News Press – Jan. 30
The ride will begin at the Moffitt Cancer Center in Tampa on Saturday and end at the steps of the state Capitol building on Tuesday. Aubuchon is riding for an organization called Cure On Wheels, which is dedicated to helping those dealing with cancer as well as funding cancer research. Since it is a non-profit organization, all of the donations are tax deductible.
After Mastectomies, an Unexpected Blow: Numb New Breasts
New York Times – Jan. 29
Dr. Christine Laronga, a breast oncologist at the Moffitt Cancer Center in Tampa, Fla., said she tried to make clear to patients that feeling would not be restored after reconstruction, telling them, “It may look like a breast, but it won’t feel like a breast.”
Sarah E. Hoffe, MD, on Pancreatic Cancer and SBRT: Pros and Cons
ASCO Post – Jan. 29
Sarah E. Hoffe, MD, of the Moffitt Cancer Center, discusses the controversial role of radiation in the treatment of pancreatic cancer, recent advances in delivering short courses of high-dose stereotactic body radiation therapy, and how best to integrate this new modality in borderline and locally advanced disease.
Moffitt Cancer Center Names Robert Wenham, MD, MS, FACOG, FACS, Gynecologic Oncology Program Chair
ASCO Post – Jan. 29
Moffitt Cancer Center has appointed Robert Wenham, MD, MS, FACOG, FACS, as the new Gynecologic Oncology Program Chair. Dr. Wenham has served as the Interim Chair over the past several months.
Hyo Sook Han, MD, on Metastatic Breast Cancer: Trial Results on Veliparib, Carboplatin, and Paclitaxel
ASCO Post – Jan. 29
Hyo Sook Han, MD, of Moffitt Cancer Center, discusses phase II study findings on the efficacy and tolerability of veliparib in combination with carboplatin and paclitaxel vs placebo in patients with BRCA1 or BRCA2 mutations and metastatic breast cancer (Abstract S2-05).
Bay News 9 – Jan. 27
Dr. Frederick Locke spoke with Bay News 9 about Car-T therapy and his ongoing research.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.